Breast cancer, Cancer spread to the brain, Secondary cancers
Results
Phase 2
This trial looked at a chemotherapy drug called cabazitaxel for people with HER2 negative breast cancer that had spread to the brain.
It was open for people to join between 2015 and 2017, and the team analysed the results in 2019.
Recruitment start: 1 October 2015
Recruitment end: 30 November 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr Zafar Malik
Amgen
Clatterbridge Cancer Centre NHS Foundation Trust
Liverpool Cancer Trials Unit
Sanofi
Last reviewed: 16 March 2021
CRUK internal database number: 11562
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
